Syngene International Ltd share price logo

Syngene International Ltd Share Price

(SYNGENE)

Small Cap

Healthcare Sector

Check the latest share price of Syngene International Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹628.9

▲1.94%

as on 04:01PM, 29 Apr 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Option Chain

Syngene International Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹612.25
    Day's Price Range
    ₹631.7

  • 52 Week's Low

    52 Week's High

    ₹607.65
    52-Week Price Range
    ₹960.6
1 Month Return+ 3.95 %
3 Month Return-14.45 %
1 Year Return-3.08 %
Previous Close₹616.95
Open₹618.00
Volume34.67L
Upper Circuit-
Lower Circuit-
Market Cap₹28,250.05Cr

Syngene International Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹28,250.05 Cr

Return on Equity (ROE)

12.89

Return on capital employed (ROCE)

11.72

P/B Ratio

7.27

Dividend Yield

0.17

EPS (TTM)

9.88

Sector

Healthcare

How to invest in Syngene International Ltd

Investing in Syngene International Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Syngene International Ltd or SYNGENE on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Syngene International Ltd or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Syngene International Ltd with just a few clicks!

Syngene International Ltd Valuation

Track how the P/E of Syngene International Ltd has moved over time to understand valuation trends.

Syngene International Ltd in the last 5 years

  • Overview

  • Trends

Lowest (23.09x)

March 31, 2020

Today (56.94x)

December 15, 2023

Industry (104.63x)

December 15, 2023

Highest (70.41x)

September 7, 2023

LowHigh

Today’s Price to Earnings Ratio: 56.94x

Analysts Recommendation on Syngene International Ltd

Get updated buy, sell, and hold recommendations by analysts on Syngene International Ltd.

based on 8 analysts

BUY

87.50%

Buy

0.00%

Hold

12.50%

Sell

87.5% of analysts recommend a 'BUY' rating for Syngene International Ltd. Average target of ₹825.12

Source: S&P Global Market Intelligence

Analysts Forecast on Syngene International Ltd

Get share price movements and forecasts by analysts on Syngene International Ltd.

Syngene International Ltd price forecast by 8 analysts

Upside of17.57%

High

₹960

Target

₹825.12

Low

₹740

Syngene International Ltd target price ₹825.12, a slight upside of 17.57% compared to current price of ₹628.9. According to 8 analysts rating.

Source: S&P Global Market Intelligence

Syngene International Ltd Financials

Get the annual and quarterly financial summary of Syngene International Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹808.10Cr (-)₹910.10Cr (↑12.62%)₹853.50Cr (↓6.22%)₹916.90Cr (↑7.43%)₹789.70Cr (↓13.87%)
Net Income₹93.40Cr (-)₹116.50Cr (↑24.73%)₹111.50Cr (↓4.29%)₹188.60Cr (↑69.15%)₹75.70Cr (↓59.86%)
Net Profit Margin11.56% (-)12.80% (↑10.73%)13.06% (↑2.03%)20.57% (↑57.50%)9.59% (↓53.38%)
Value in ₹ crore
Details2019202020212022
Total Assets₹3,735.40Cr (-)₹4,247.60Cr (↑13.71%)₹4,977.30Cr (↑17.18%)₹5,686.00Cr (↑14.24%)
Total Liabilities₹1,768.20Cr (-)₹2,073.50Cr (↑17.27%)₹2,159.00Cr (↑4.12%)₹2,394.00Cr (↑10.88%)
Value in ₹ crore
Details20182019202020212022
Operating Cash Flow₹445.60Cr (-)₹629.80Cr (↑41.34%)₹677.40Cr (↑7.56%)₹698.00Cr (↑3.04%)₹582.20Cr (↓16.59%)

Syngene International Ltd Index Inclusions

BSE 500

₹34,765.79

0 (▲0%)

S&P BSE 150 MidCap

₹14,959.91

0 (▲0%)

Nifty 500

₹0.00

0 (▲0%)

S&P BSE SmallCap Select

₹7,178.77

0 (▲0%)

BSE Healthcare

₹42,555.65

0 (▲0%)

Nifty LargeMidcap 250

₹15,416.05

0.1 (▲15.35%)

BSE Small-Cap

₹48,193.46

0 (▲0%)

S&P BSE 250 LargeMidCap

₹10,383.27

0 (▲0%)

S&P BSE 400 MidSmallCap

₹11,171.57

0 (▲0%)

Nifty Healthcare

₹13,992.20

-0.88 (▲-124.05%)

Nifty Midcap 150

₹20,009.05

0.21 (▲42.35%)

Nifty MidSmallcap 400

₹18,431.30

0.21 (▲38.8%)

S&P BSE AllCap

₹10,471.31

0 (▲0%)

Syngene International Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Syngene International Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
54.88%
0.00
Foreign Institutions
23.3%
0.00
Mutual Funds
8.35%
0.00
Retail Investors
10.63%
0.00
Others
2.84%
0.00

Syngene International Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Syngene International Ltd with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Syngene International Ltd
Syngene International Ltd
BUY₹28,250.05 Cr30.32%0.64NANA
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
BUY₹63,424.92 Cr22.06%0.55NANA
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd
BUY₹87,426.64 Cr31.24%0.59NANA
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd
HOLD₹46,605.29 Cr17.26%0.55NANA
Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd
HOLD₹16,637.10 Cr6.43%0.57NANA
See all

Syngene International Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in Syngene International Ltd.

  • Syngene Declares Dividend Amid Slower Growth Outlook - 28 Apr, 2025

    Syngene International declared a final dividend of Re.1.25 per share for FY25. The company anticipates slower growth in FY26 due to inventory adjustments and expansion costs, despite maintaining strong underlying business momentum.

  • Syngene International Faces Significant Stock Decline - 24 Apr, 2025

    Syngene International's stock fell sharply due to disappointing Q4 results, a decline in net profit, and cautious guidance for FY26, leading to investor concerns.

  • Syngene Reports Mixed Q4 Results with Record Revenue - 23 Apr, 2025

    Syngene International reported a net profit of ₹183.3 crore for Q4, up 2.8%, while revenue reached ₹1,018 crore, marking a record. Despite missing revenue estimates, the company announced a dividend of ₹1.25 per share and saw strong growth in its biologics CDMO sector. Shares closed 2.5% higher ahead of the earnings announcement.

  • Syngene International Board to Discuss Final Dividend - 14 Apr, 2025

    Syngene International's Board of Directors will meet on April 23, 2025, to approve Q4 financial results and consider a final dividend proposal for shareholders.

  • Peter Bains Appointed CEO; Syngene Reports Growth - 02 Apr, 2025

    Syngene International appointed Peter Bains as MD & CEO effective April 1. The company reported a 17.58% increase in Q3 FY25 profit and acquired a US biologics facility for $36.5 million.

Insights on Syngene International Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 839.8 Cr → 1.03K Cr (in ₹), with an average increase of 6.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 75.7 Cr → 183.3 Cr (in ₹), with an average increase of 25.4% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 15.40% to 17.86% in Mar 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 52.74% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 88.8% return, outperforming this stock by 100.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 195.0% return, outperforming this stock by 196.6%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 6.80% to 6.00% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 20.64% to 19.47% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SYNGENE stock has moved down by -16.1%

About Syngene International Ltd

Syngene International Limited is a India-based research, development, and manufacturing services organization driven by a team of 5200 scientists. It focuses primarily on the pharmaceutical and biotechnology sectors, and also provides services for nutrition, animal health, consumer goods, and other chemical sectors. The company’s health-related services extends across all major therapy areas and modalities. The operations are spread across 2 million sq. ft. with facilities at Bangalore, Hyderabad, and Mangalore. Syngene International Limited was incorporated in 1993 and consistently has entered into partnerships for research and development. This helped Syngene International cross an annual turnover of Rs 1000 crore in the year 2016. Over the years leading up to 2021, Syngene International expanded its research collaboration with companies such as Abbott, Bristol Myers Squibb, Herbalife, and Glaxo Smith Kline. It also commissioned new facilities and added bioreactors and microbial manufacturing capacity to strengthen biologics manufacturing. With investments in R&D and strengthening scientific capabilities, Syngene International continues to provide integrated drug discovery services.

Revenue: ₹789.70Cr as on June 2024 (Q2 24)
Net Profit: ₹75.70Cr as on June 2024 (Q2 24)
Listing date: 11 Aug, 2015
Chairperson Name: Kiran Mazumdar Shaw
OrganisationSyngene International Ltd
Headquarters
IndustryHealthcare
E-voting on sharesClick here to vote

Indian Mutual Funds that own Syngene International Ltd

Check out the Mutual Funds with significant holdings in Syngene International Ltd.

Futures and Options

View the latest movement in Syngene International Ltd Futures & Options, including strike prices, expiry dates, and percentage changes.

FAQs

What is Syngene International Ltd price today?

Syngene International Ltd share price today stands at ₹628.9, Open: ₹618, Previous Close: ₹616.95, High: ₹631.7, Low: ₹612.25, 52 Week High: ₹960.6, 52 Week Low: ₹607.65.

How to Buy Syngene International Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Syngene International Ltd shares

What are today's traded volumes of Syngene International Ltd?

Today's traded volume of Syngene International Ltd(SYNGENE) is 34.67L.

What is today's market capitalisation of Syngene International Ltd?

Today's market capitalisation of Syngene International Ltd(SYNGENE) is ₹28,250.05 Cr.

What is the 52 Week High and Low Range of Syngene International Ltd?

Syngene International Ltd (SYNGENE)
Price
52 Week High
₹960.6
52 Week Low
₹607.65

How much percentage Syngene International Ltd is down from its 52 Week High?

Syngene International Ltd (SYNGENE) share price is ₹628.9. It is down -34.53% from its 52 Week High price of ₹960.6

How much percentage Syngene International Ltd is up from its 52 Week low?

Syngene International Ltd (SYNGENE) share price is ₹628.9. It is up 3.50% from its 52 Week Low price of ₹607.65